Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Love Lifesciences

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

Open the dossier
Opportunities
5
High confidence
070% and above
Counterparts
5startups and investors
  • Co-development 2
  • Investors 2
  • Peers 1

Co-development2

An integration or joint product

Early device partnership for injectable nanobody formulations

Nanogrow develops nanobody biologics with an injectable route among others and is still preclinical, the phase when device choices are cheapest to make. Co-developing a vial-plus-UniPen presentation gives Love Lifesciences a first biologic programme and Nanogrow a low-cost self-administration option.

20%confidence

Evidence from the records

  • “Nanobody (sdAb) platform combined with local delivery formulations: topical, nebulized, injectable, oral or via DNA/RNA.”
  • “UniPen universal injector pen compatible with standard vials, for self-administration of drugs.”
If it works
A letter of intent naming UniPen as the candidate device for one programme, useful for both companies' fundraising.
First step
Share UniPen's viscosity/volume envelope with Nanogrow's formulation team.

Explore lower-cost manufacturing through Byonyks' Pakistan factory

Byonyks runs a regulator-approved device factory in Pakistan and has cleared a class II home-therapy device with the FDA. A contract-manufacturing or know-how arrangement could cut UniPen's unit cost and accelerate regulatory documentation; Byonyks fills factory capacity.

20%confidence

Evidence from the records

  • “DRAP-approved factory in Pakistan”
  • “FDA 510(k) clearance K243371 (decision of 16 May 2025, class II)”
  • “reduce costs and lead times for pharmaceutical companies”
If it works
A manufacturing quote and regulatory-pathway mentoring that de-risk the FDA plan.
First step
Ask Byonyks for its contract-manufacturing capabilities and ISO certification scope.

Investors2

A fund whose thesis fits

Pitch Robin Hood Ventures via Vytala Health

Robin Hood Ventures is a US angel network investing $0.25–0.5M at pre-seed/seed in HealthTech and life sciences, matching Love Lifesciences' stage. It led Vytala Health's round in the network, providing a warm introduction.

35%confidence

Evidence from the records

  • “Robin Hood Ventures (lead), Delaware Crossing Investment Group, Ulu Ventures, The MBA Fund, JumpStart NJ, business angel groups”
  • “~$1.2M (WIBW); $1.72M over 5 rounds according to CB Insights”
If it works
A seed cheque to fund the FDA pathway.
First step
Ask Vytala Health's founders for an introduction to Robin Hood Ventures' screening lead.

Use PharmStars' pharma network to land a first partner

PharmStars invests at pre-seed/seed in HealthTech and life sciences globally and is oriented to pharma partnerships, addressing Love Lifesciences' main gap (no pharma partner). It led Cromodata's round in the network.

30%confidence

Evidence from the records

  • “PharmStars Ventures (lead), Sancus Capital, Gabriela Pittis (business angel)”
  • “UniPen available through licensed pharmacies (not FDA-authorized); no pharma customer or partner named.”
If it works
Investment plus introductions to pharma device teams.
First step
Ask Cromodata's CEO for an intro to PharmStars and prepare a pharma-facing value proposition.

Peers1

Founders solving the same problem elsewhere

Share FDA and QMS learnings between two pre-clearance drug-delivery devices

Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

25%confidence

Evidence from the records

  • “No public evidence of traction found: pump shown as a concept visual; funds intended for R&D, clinical validation and the FDA pathway.”
  • “High risk: regulatory (FDA), competition from BD/Ypsomed and little capital.”
If it works
Lower regulatory preparation costs through shared vendors.
First step
Set a call between the two founders to compare FDA pathway plans.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. BelliwithGolden Gate VenturesInvestors
    Pitch Series A to an Asia–Middle East early-stage VC

    Belli's revenue base sits exactly in Golden Gate's footprint: Singapore HQ, Southeast Asian carriers and Gulf flag carriers. Golden Gate invests Seed to Series A, the stage Belli is approaching, and already backed BioSapien in the network, which gives a warm founder-to-founder introduction.

    50%
  2. PraxilabswithMaria EducaçãoDistribution
    Embed PraxiLabs experiments into Maria Educação's learning paths in Brazil

    Maria Educação already sits inside Brazilian publishers, school networks and 80+ municipalities with an AI diagnostic that prescribes learning paths; it lacks a hands-on science layer. Plugging PraxiLabs simulations as prescribed activities gives PraxiLabs a paid B2B2G channel into Brazil and gives Maria Educação a differentiating STEM remediation module.

    50%
  3. VenditekwithPulster.aiCo-development
    Use Pulster NOVA to place and price every new machine

    Vending profitability is a location game, and Pulster sells site assessment and cannibalisation models to 49 Latin American retail brands from the same country. Venditek gets data-driven placement; Pulster gets a new micro-format use case and a joint offer to its retail clients.

    50%
  4. ORA TechnologieswithPwn&PatchCustomers
    Buy continuous threat-exposure management for the payments stack

    A payment super-app is a prime target for fraud and intrusion, and regulators expect continuous security testing. Pwn&Patch, a North African offensive-security firm with a CTEM platform, can cover attack-surface monitoring and continuous pentesting in French/Arabic, at regional cost. ORA reduces regulatory and breach risk; Pwn&Patch wins a flagship fintech reference in Morocco.

    50%
  5. Piezo Sonic CorporationwithProxima RoboticsCo-development
    Run Proxima Compass on Mighty AMR

    Piezo Sonic's differentiation is the rough-terrain chassis and drive, not fleet software; Proxima sells a hardware-agnostic navigation and flow-management layer to robot makers. Bundling Compass on Mighty AMR gives Piezo a proven European navigation stack and gives Proxima an outdoor, all-terrain reference platform beyond indoor AGVs.

    50%
  6. PraxilabswithKetzaiDistribution
    Insert virtual labs into Ketzai's AI-generated lesson plans

    Ketzai generates curriculum-aligned lesson plans for a large teacher base in Central America and the Caribbean; inserting PraxiLabs experiments as one-click activities converts lesson planning into lab usage. PraxiLabs gains Spanish-speaking teacher acquisition at near-zero CAC; Ketzai gains a premium content upsell.

    45%
  7. Proxima RoboticswithPiezo Sonic CorporationCo-development
    Port Compass to Piezo Sonic's all-terrain AMR

    Piezo Sonic builds rough-terrain AMRs and sells through Japanese trading houses; Proxima sells navigation software. A port opens outdoor robotics and an Asian channel for Proxima.

    45%
  8. Pwn&PatchwithORA TechnologiesCustomers
    Win ORA's super-app as a flagship fintech client

    ORA's payment super-app is exposed to regulatory and fraud risk and has no documented security partner. A continuous testing contract gives Pwn&Patch a Moroccan reference in fintech.

    45%
  9. UnitSensewithOrbisCustomers
    Cut Orbis's triple-model interview cost

    Orbis scores every interview with three independent AI models voting by majority, which multiplies inference cost per candidate in a price-sensitive SME market (Jordan, GCC, Egypt). UnitSense's per-request attribution and cheapest-good-enough routing directly targets that cost structure and gives Orbis a per-customer margin view.

    45%
  10. GreenirrwithAZ ShipDistribution
    Embed an emissions module in AZ Ship's TMS for Brazilian agri-shippers

    AZ Ship's TMS already centralises loads, carriers and delivery proofs for global agri-commodity shippers who carry Scope 3 targets. Adding Greenirr's per-shipment emissions calculation turns existing TMS data into reportable carbon figures; AZ Ship gains an ESG upsell and Greenirr a first international, channel-led market.

    45%
  11. AstrolightwithSeraphim SpaceInvestors
    Series A from a specialist space investor

    Seraphim invests globally in space and deep tech addressing security and resilience, from Seed onwards, and appears among G-Space's investors in the network. Astrolight's dual-use optical links fit that thesis precisely.

    40%
  12. ChonexwithCavallo VenturesInvestors
    Bring an agri CVC into the Series A

    Cavallo Ventures is an agri-focused CVC investing from seed to Series B and backed network member ZymoChem. A strategic agri investor fits Chonex's $6M Series A and can accelerate distribution.

    40%
  13. CredncewithMicrotractionInvestors
    Pitch a pre-seed fund whose ticket matches the round

    Crednce is raising $175,000; Microtraction writes $0.1–0.35M pre-seed tickets in Africa with FinTech in its sectors and Ghana in its geographies. The ticket and stage fit are exact, which is rare for a pre-traction fintech.

    40%
  14. TausiwithHairCoSys LimitedDistribution
    Distribute AI scalp analysis to Tausi's beauticians

    HairCoSys sells AI hair and scalp analysis tools used by Hong Kong salons. Tausi's beauticians could offer diagnostics as a premium service, making the AI claim concrete and opening Africa for HairCoSys.

    40%
  15. License TIBOK as a white-label engine for Baika

    Instead of building its own stack, Teramed could run Baika+Saúde on TIBOK's white-label OS (own brand, WhatsApp and phone numbers, Portuguese workspace) with pay-per-consultation pricing. It accelerates launch and reduces capex; TIBOK gains an Angolan distributor.

    40%
  16. TerraSparkwithSeraphim SpaceInvestors
    Target Seraphim Space for the seed round

    Seraphim invests globally in space and climate deep tech from seed onward, with a resilience thesis that covers energy security. It backed network member G-Space, giving a warm path to a seed lead after the 2026 demonstration.

    40%
  17. Thistle OÜwithOmniLoc AICo-development
    Integrate GPS-free localisation into Thistle Shield

    Counter-drone engagements happen where GPS is jammed or spoofed, often by the defender itself. OmniLoc's camera-to-satellite matching keeps autonomous platforms positioned without GPS, a direct building block for Thistle's autonomy and a field deployment for OmniLoc.

    40%
  18. Thistle OÜwithNATO DIANAInvestors
    Apply to NATO DIANA with the trial results

    NATO DIANA supports pre-seed and seed dual-use start-ups across Europe and North America, exactly Thistle's stage. Network member Astrolight is in the DIANA programme and can coach the application.

    40%
  19. TIBOKwithTERAMED SISTEMAS DE SAÚDE, SAMarket entry
    Power Teramed’s Angolan teleconsultation and corporate health offer as white-label

    Teramed holds the local positioning in Angola (corporate health, 24/7 GP teleconsultation, hospital booking) but shows no traction or disclosed technology depth; TIBOK offers exactly the white-label OS model already signed with C-Care. Teramed would become a Portuguese-speaking distributor, opening Angola without TIBOK building a local entity.

    40%
  20. EqorewithPolyJouleCustomers
    Deploy non-flammable polymer batteries at sensitive sites

    Some industrial sites have strict fire codes; PolyJoule's non-flammable, UL9540A-certified polymer batteries suit them. Eqore gains a differentiated product, PolyJoule a deployment channel.

    40%

Similar profiles

Compatibility score with Love Lifesciences

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.